These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27913311)

  • 1. Should travelers be screened for multi-drug resistant (MDR) bacteria after visiting high risk areas such as India?
    Petersen E; Mohsin J
    Travel Med Infect Dis; 2016; 14(6):591-594. PubMed ID: 27913311
    [No Abstract]   [Full Text] [Related]  

  • 2. Is screening patients for antibiotic-resistant bacteria justified in the Indian context?
    Bhattacharya S
    Indian J Med Microbiol; 2011; 29(3):213-7. PubMed ID: 21860099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Travels and spreading of multi-resistant bacteria].
    Nitsch-Osuch A
    Pol Merkur Lekarski; 2017 May; 42(251):219-222. PubMed ID: 28557971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening at admission for carrier prevalence of multidrug-resistant organisms in a pediatric unit.
    Tarchouna M; Ferjani A; Tilouche S; Marzouk M; Bouguila J; Boughamoura L; Boukadida J
    Am J Infect Control; 2014 Jan; 42(1):88-9. PubMed ID: 24388477
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug-resistant organisms among refugees in Germany: we need evidence-based care, not fear-based screening.
    Seybold U; Wagener J; Jung J; Sammet S
    J Hosp Infect; 2016 Mar; 92(3):229-31. PubMed ID: 26810611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiology of multidrug-resistant organisms in travellers: Results of a 2-year screening in a German level 1 trauma center].
    Seifert J; Frank M; Köln T; Beniers K; Kramer A; Ekkernkamp A; Gümbel D
    Unfallchirurg; 2016 Mar; 119(3):217-24. PubMed ID: 25394753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome.
    Nemeth J; Ledergerber B; Preiswerk B; Nobile A; Karrer S; Ruef C; Kuster SP
    J Hosp Infect; 2012 Dec; 82(4):254-9. PubMed ID: 23103249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Travellers and multi-drug resistance bacteria].
    Takeshita N
    Nihon Rinsho; 2012 Feb; 70(2):324-8. PubMed ID: 22413540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients hospitalized abroad as importers of multiresistant bacteria-a cross-sectional study.
    Khawaja T; Kirveskari J; Johansson S; Väisänen J; Djupsjöbacka A; Nevalainen A; Kantele A
    Clin Microbiol Infect; 2017 Sep; 23(9):673.e1-673.e8. PubMed ID: 28196696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study.
    Epelboin L; Robert J; Tsyrina-Kouyoumdjian E; Laouira S; Meyssonnier V; Caumes E;
    J Travel Med; 2015; 22(5):292-9. PubMed ID: 25997830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonization of Libyan civil war casualties with multidrug-resistant bacteria.
    Koole K; Ellerbroek PM; Lagendijk R; Leenen LP; Ekkelenkamp MB
    Clin Microbiol Infect; 2013 Jul; 19(7):E285-7. PubMed ID: 23413838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant bacteria in solid organ transplant recipients.
    Cervera C; van Delden C; Gavaldà J; Welte T; Akova M; Carratalà J;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():49-73. PubMed ID: 24861521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.
    Mutters NT; Günther F; Frank U; Mischnik A
    J Hosp Infect; 2016 Jun; 93(2):191-6. PubMed ID: 27112045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active screening of multi-drug resistant bacteria effectively prevent and control the potential infections.
    Ren Y; Ma G; Peng L; Ren Y; Zhang F
    Cell Biochem Biophys; 2015 Mar; 71(2):1235-8. PubMed ID: 25416582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of multi-drug-resistant organism carriage in pregnant women.
    Knowles SJ; Jacob AM; O'Dea G
    J Hosp Infect; 2016 May; 93(1):68-9. PubMed ID: 27021400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of health care associated infections and bacterial resistance : guidance for good practice].
    Foguena AK; Cometta A; Senn L
    Rev Med Suisse; 2016 Nov; 12(540):2026-2032. PubMed ID: 28696611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of multiresistant bacteria].
    Ramé A
    Rev Infirm; 2006 May; (121):32-3. PubMed ID: 16792047
    [No Abstract]   [Full Text] [Related]  

  • 19. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia.
    Molton JS; Tambyah PA; Ang BS; Ling ML; Fisher DA
    Clin Infect Dis; 2013 May; 56(9):1310-8. PubMed ID: 23334810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection control strategy by killing drug-resistant bacteria.
    Siddiqui R; Khan NA
    Pathog Glob Health; 2013 Jul; 107(5):215-6. PubMed ID: 23916330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.